McHorney, Colleen A.
Bensink, Mark E.
Burke, Laurie B.
Belozeroff, Vasily
Gwaltney, Chad
Funding for this research was provided by:
Amgen
Article History
Received: 7 August 2017
Accepted: 24 January 2018
First Online: 13 February 2018
Ethics approval and consent to participate
: Institutional Review Board (IRB) submission and approval from Quorum Review IRB for the study was secured by DaVita Clinical Research who maintained appropriate documentation and conducted management of the study in accordance with the ethical principles consistent with Good Clinical Practice and applicable regulatory requirements. Written informed consent from patients was obtained.
: Not applicable. No individual-patient data reported.
: Drs. Mark E. Bensink and Vasily Belozeroff are employed by, and stockholders in, Amgen Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.